Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • News & Views
  • Published:

Epigenetics

Catching active enhancers via H2B N-terminal acetylation

Specific chromatin features, especially histone H3 lysine 27 acetylation, are widely used to identify active enhancers, yet current methods are imprecise. New work suggests that histone H2B N terminus multisite lysine acetylation (H2BNTac) is a notable signature of active enhancers and could substantially improve enhancer prediction.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Fig. 1: H2BNTac marks active enhancers.

References

  1. Narita, T. et al. Nat. Genet. https://doi.org/10.1038/s41588-023-01348-4 (2023).

    Article  PubMed  Google Scholar 

  2. Schoenfelder, S. & Fraser, P. Nat. Rev. Genet. 20, 437–455 (2019).

    Article  CAS  PubMed  Google Scholar 

  3. Shlyueva, D., Stampfel, G. & Stark, A. Nat. Rev. Genet. 15, 272–286 (2014).

    Article  CAS  PubMed  Google Scholar 

  4. Heintzman, N. D. et al. Nat. Genet. 39, 311–318 (2007).

    Article  CAS  PubMed  Google Scholar 

  5. Wang, Z. et al. Nat. Genet. 40, 897–903 (2008).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  6. Heintzman, N. D. et al. Nature 459, 108–112 (2009).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  7. Creyghton, M. P. et al. Proc. Natl Acad. Sci. USA 107, 21931–21936 (2010).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  8. Weinert, B. T. et al. Cell 174, 231–244 e12 (2018).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  9. Kumar, V. et al. Genome Res. 26, 612–623 (2016).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  10. Zhang, T., Zhang, Z., Dong, Q., Xiong, J. & Zhu, B. Genome Biol. 21, 45 (2020).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  11. Sankar, A. et al. Nat. Genet. 54, 754–760 (2022).

    Article  CAS  PubMed  Google Scholar 

  12. Narita, T. et al. Mol. Cell 81, 2166–2182 e6 (2021).

    Article  CAS  PubMed  Google Scholar 

  13. Hogg, S. J. et al. Mol. Cell 81, 2183–2200 e13 (2021).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  14. Durrin, L. K., Mann, R. K., Kayne, P. S. & Grunstein, M. Cell 65, 1023–1031 (1991).

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Kristian Helin.

Ethics declarations

Competing interests

K.H. is a co-founder of Dania Therapeutics and a scientific advisor for Hannibal Innovation. He was recently a scientific advisor for Inthera Bioscience AG and MetaboMed Inc. C.H. declares no competing interests.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Huang, C., Helin, K. Catching active enhancers via H2B N-terminal acetylation. Nat Genet 55, 525–526 (2023). https://doi.org/10.1038/s41588-023-01347-5

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/s41588-023-01347-5

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing